Clinical Research Grant Awards are one of the two largest types of grants awarded by DSF. These grants are intended for established, experienced, independent investigators affiliated with a research or academic institution whose proposed projects have a clinical focus and investigate hypotheses directly related to Dravet syndrome. Proposals are scored according to NIH guidelines based on the quality of preliminary data, research design, feasibility, investigator’s qualifications, and overall impact. Grants are awarded for $150,000 over 2 years (beginning January 1 of each year), with indirect costs not to exceed 10% of the award.
Investigators applying for a research grant should ensure their proposed project addresses the needs of the Dravet syndrome community and DSF’s mission to support research toward better treatments and a cure for Dravet syndrome.
Eligibility: Applicants should be affiliated with a research or academic institution (excluding for-profit companies), may be US or foreign based, established in their field, and in good standing with their institution.
Our 2021 priority areas include:
● Research that helps identify patient trends, characteristics, epidemiology, or other clinical aspects of Dravet syndrome and/or its comorbidities
● Research that helps to understand, predict, and prevent SUDEP
● Research that will encourage the development of novel therapies to prevent onset or halt the progression of the Dravet syndrome
Applications are due by Friday, September 10, 2021.
Please email Veronica with any questions.